Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms

<p>Supplementary Table 1</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Lindsay M. Gurska (15056629) (author)
Daljnji autori:	Rachel Okabe (15056632) (author), Alexandra Schurer (15056635) (author), Meng Maxine Tong (15056638) (author), Mark Soto (15056641) (author), Daniel Choi (15056644) (author), Kristina Ames (15056647) (author), Shira Glushakow-Smith (15056650) (author), Allison Montoya (15056653) (author), Ellen Tein (15056656) (author), Linde A. Miles (15056659) (author), Haiying Cheng (15056662) (author), Pamela Hankey-Giblin (15056665) (author), Ross L. Levine (15056668) (author), Swati Goel (15056671) (author), Balazs Halmos (15056674) (author), Kira Gritsman (15051360) (author)
Izdano:	2025
Teme:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling Receptors Hematological Cancers Small Molecule Agents Kinase inhibitors Translational Research
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti